01 Fehorizon Released Its 2024 Mid-year Report

On August 9, Fehorizon released its 2024 mid-year report in Hong Kong. The meeting was attended by Mr. Kong Fanxing (Chairman, Executive Director and CEO of Fehorizon), Mr. Wang Mingzhe (Executive Director and CFO of Fehorizon), and Mr. Cao Jian (Executive Director and Senior Vice President of Fehorizon). During the meeting, the Company’s management personnel carried out in-depth exchanges with attendees regarding Fehorizon’s 2024 mid-year performance and market focus areas including asset placement, interest margin trend, dividend policy and future business strategy. An analyst present at the meeting indicated that, under the current environment, the Company still maintained the security and stability of its basic business as well as the steadiness and prudence of its business strategy, and especially improved shareholder returns, which has received complete recognition from investors. 

02 CDHORIZON Released Its 2024 Mid-year Report

On August 8, CDHORIZON released its 2024 mid-year report in Hong Kong. The meeting was attended by Mr. Pan Yang (Executive Director and CEO of CDHORIZON), Mr. Tang Li (Executive Director and Co-CFO of CDHORIZON), Mr. Shen Liang (COO of CDHORIZON) and Mr. Deng Huanan (Co-CFO of CDHORIZON). In 2024, guided by its controlling shareholder Fehorizon’s “finance + industry” strategy, CDHORIZON consolidated its dominant position in the market with “quality” and injected an inexhaustible driving force for the Company’s development with “innovation,” meanwhile promoting exploitation surrounding “three new” aspects and accelerating its overseas market layout to realize steady and high-quality growth.

03 Fehorizon Leasing Issued ABS in Scientific and Technological Innovation

Recently, International Far Eastern Leasing Co., Ltd. and Far East Horizon (Tianjin) Financial Leasing Co., Ltd. successfully issued the “Yuan Jian Series—2024 Far East Phase I Asset-backed Special Plan for Scientific and Technological Innovation” in Shenzhen Stock Exchange. With a scale of about 1.2 billion yuan and underlying assets mainly covering the technology industry supported by the national strategy of scientific and technological finance, this Plan has been received with active participation by numerous investors. The successful issuance of the Special Plan fully demonstrates the diversified characteristic financial services developed by Fehorizon, and adds another vivid example of the Company’s practice of empowering technology business with every effort and contributing to the development of new-quality productivity.

04 Fehorizon International Implemented Its First Special Opportunity Business

Recently, utilizing the strengths of Fehorizon, Fehorizon International worked closely with certain Chinese-funded bank in Hong Kong and completed the first “back-to-back” cross-border transaction of NPL purchase. With elaborately designed bidding & acquisition process and efficient disposal & transfer strategy, under the premise of ensuring risk controllability, the project has realized mutual benefit and a win-win result. At present, Fehorizon International has signed multiple cooperation agreements with financial institutions in Hong Kong, to provide diversified services for meeting the requirements of special opportunity business and give further play to the advantages of “marketization, internationalization and specialization”.

05 Fehorizon International Successfully Contributed to the Global Layout of Certain A-share Listed Company

Lately, in active response to the global layout demand of certain A-share main board listed company, Fehorizon International offered a one-stop integrated solution to overseas financing. On the one hand, it effectively advanced the internal process and quickly provided the client with millions of US dollars of funds; on the other hand, through synchronous coordination of multiple overseas banks, it followed up with even more incremental funds to help its client to meet the capital needs of a global layout. During this process, the team won a high degree of recognition from its client with professionalism and international experience, which also lays a good foundation for establishing a long-term win-win partnership subsequently. 

06 HCHORIZON Conducted Cooperation and Exchange with Cedars-Sinai Medical Center (US)

On August 12, Dr. Kong Yawei—Asia Managing Director and International Medicine Director of Cedars-Sinai Medical Center (US) —visited the FEHORIZON Plaza in Shanghai, and talked with Mr. Li Jiancheng, Vice President of Fehorizon and General Manager of HCHORIZON. Since the successful MOU signing in the US this June, this visit of Dr. Kong Yawei indicates further deepening of the cooperation and exchange between Fehorizon and Cedars-Sinai Medical Center. Both parties talked about cooperation modes including international diagnosis, doctor training program in the US and construction of key disciplines, and discussed issues regarding cooperation and exploration in frontier medicine. The talk was also participated by HCHORIZON’s GM Assistant Mr. Han Jiajie.

In August we forged ahead with great strides; in September, Fehorizon shall keep slashing through the waves on the journey towards excellence.